| Gary Cheung, | |
|
4025 N 92nd St, Milwaukee, WI 53222-1613 | |
| (414) 243-6123 | |
| Not Available |
| Full Name | Gary Cheung |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 9 Years |
| Location | 4025 N 92nd St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326410002 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 71-17 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aurora Medical Center - Grafton | Grafton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
The Center for American Progress proposed a "fail-safe" mechanism designed to ensure that a health care overhaul wouldn't add to the federal deficit today. The plan, part of a financing proposal for health care legislation that was released at a breakfast with reporters, is aimed at addressing concerns that a revamping might not produce expected cost savings over the long run, leading to a big increase in the budget gap.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of the Journal of Nuclear Medicine.
The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.
The results of this research, involving a study of the activity of the protein interleukin 1 in the brain, comprise not only a breakthrough in understanding the regulation of bone density by the brain but also hold promise for the development of future treatment for osteoporosis, say the researchers.
› Verified 4 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
The Center for American Progress proposed a "fail-safe" mechanism designed to ensure that a health care overhaul wouldn't add to the federal deficit today. The plan, part of a financing proposal for health care legislation that was released at a breakfast with reporters, is aimed at addressing concerns that a revamping might not produce expected cost savings over the long run, leading to a big increase in the budget gap.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of the Journal of Nuclear Medicine.
The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.
The results of this research, involving a study of the activity of the protein interleukin 1 in the brain, comprise not only a breakthrough in understanding the regulation of bone density by the brain but also hold promise for the development of future treatment for osteoporosis, say the researchers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary Cheung, 6989 Eastwood Trl, West Bend, WI 53090-8915 Ph: (414) 243-6123 | Gary Cheung, 4025 N 92nd St, Milwaukee, WI 53222-1613 Ph: (414) 243-6123 |
News Archive
The Center for American Progress proposed a "fail-safe" mechanism designed to ensure that a health care overhaul wouldn't add to the federal deficit today. The plan, part of a financing proposal for health care legislation that was released at a breakfast with reporters, is aimed at addressing concerns that a revamping might not produce expected cost savings over the long run, leading to a big increase in the budget gap.
Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.
Several newly identified markers could provide valuable insight to predict the risk of rupture abdominal aortic aneurysms (AAA), according to new research published in the October issue of the Journal of Nuclear Medicine.
The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.
The results of this research, involving a study of the activity of the protein interleukin 1 in the brain, comprise not only a breakthrough in understanding the regulation of bone density by the brain but also hold promise for the development of future treatment for osteoporosis, say the researchers.
› Verified 4 days ago
Justin Michael Cole, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2901 W Kinnickinnic River Pkwy Ste 305, Milwaukee, WI 53215 Phone: 414-649-6000 | |
Mackenzie Lynn Reid, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Aysha T Muhammad, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Anjali Rajan Menon, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8700 Fax: 414-259-1522 | |
Joseph Shaoul, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 945 N 12th St, Milwaukee, WI 53233 Phone: 414-219-2000 | |
Mrs. Lea Van Heule, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 231-288-3155 | |
Sarah Anderson, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 2900 W Oklahoma Ave, Milwaukee, WI 53215 Phone: 414-649-6000 |